PT - JOURNAL ARTICLE AU - Joe Garman AU - Sean MacAvaney AU - Eugene Yang AU - Ophir Frieder TI - SIDIR: Extending SIR with Detected and Isolated Populations for Pandemic Modeling AID - 10.1101/2020.07.20.20157834 DP - 2020 Jan 01 TA - medRxiv PG - 2020.07.20.20157834 4099 - http://medrxiv.org/content/early/2020/07/26/2020.07.20.20157834.short 4100 - http://medrxiv.org/content/early/2020/07/26/2020.07.20.20157834.full AB - We extend the Susceptible Infected Recovered (SIR) model to include Detected (D) and Isolated (I) compartments (SIDIR). SIDIR improves COVID-19 outbreak behavior modeling by identifying infected populations as subsequently quarantined to reduce the spread of the infection (either in a hospital or self-quarantined). We present the model and provide a case study on COVID-19. The model estimates undetected cases (i.e., those infected but unconfirmed) and extrapolates when no additional undetected active (rogue) cases will remain, potentially guiding policy decisions that help control the spread of COVID-19 and future epidemics. A live demonstration of SIDIR on COVID-19 is available at: http://ir.cs.georgetown.edu/sidir.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research received no external funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Georgetown IRB. Since all the data to be gathered for the study is publicly available, the study does not meet the definition of research on human subjects, and does not need to be submitted for IRB approval.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is publicly available from the COVID-19 Data Repository by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. https://github.com/CSSEGISandData/COVID-19